Navigation Links
Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
Date:7/15/2009

search Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical Research Inc., a clinical development group; Eisai Inc., a commercial operation with manufacturing and marketing/sales functions; and Eisai Machinery U.S.A., which markets and maintains pharmaceutical manufacturing machinery.


'/>"/>
SOURCE Eisai Corporation of North America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
2. Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
3. Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement
4. Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...d Latin American countries have an opportunity to ...Researchers from the University of Valencia (UV), ... studied the productive fabric of the Spanish biot...,s food and plant sectors have more clout than tho...y as applied to food and plants has been overlooke...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Ce... announced today that the Ninth Circuit Court of A...led that CTI should be allowed to pursue all of it...back to the District Court for trial. CTI filed a...ird-party reimbursement consultant for CTI,s produ...
(Date:11/19/2009)... SEATTLE, Nov. 19 Omeros...dited financial results for the third quarter ende...eptember 30, 2009, Omeros reported a net loss of $...net loss of $7.4 million, or $2.54 per share, for ... September 30, 2009, the Company reported a net lo...
(Date:11/19/2009)..., MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRN...Decision Resources find that the leading driver of...urope is broad-spectrum activity against gram-posi...ty of organisms that can cause nosocomial pneumoni...ook primarily for agents that provide appropriate ...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...EC CITY, April 29 /PRNewswire-FirstCall/ - AEterna...al biopharmaceutical company focused on endocrine ...ved notification from the Nasdaq Stock Market ("Na...g Rule 5450 (a) (1) relating to the maintenance of... Company was required to evidence a closing bid pr...
...STOCKHOLM, Sweden, April 29 , - Results to be... Pharmalink AB announced today that it has comp...acy and safety of Nefecon(R) in IgA nephropathy, a...ease. Nefecon is an enteric,formulation of a local...nflammatory process in the kidneys through suppres...
...DE shares will continue to trade as usual pending ...il 28 deCODE genetics (Nasdaq: DCGN ) announced...he Nasdaq Listing and Hearing Review Council stati...l 22 determination of the Nasdaq Listing Qualifica...,s common stock from the Nasdaq Stock Market. Pend...
Other Biology Technology:Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R) 2Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R) 3Nasdaq Stays Suspension of Trading in deCODE Stock 2Nasdaq Stays Suspension of Trading in deCODE Stock 3
(Date:11/22/2009)...rine Life scientists have inventoried an astonishi...ea species that have never known sunlight - creatu... world down to 5,000 meters (~3 miles) below the o...sonar and other vanguard technologies, animals kno...ber 17,650, a diverse collection of species rangin...
(Date:11/22/2009)...A November 23, 2009 Agios Pharmaceuticals today ...r the first time, that the mutated IDH1 gene has a...using gene, or oncogene. This breakthrough discove...metabolite, 2-hydroxyglutarate (2HG), which may co...n of gliomas, the most common type of brain cancer...
(Date:11/20/2009)...hers are at work on many scientific and technologi... recently provided support that totals nearly $4.3...investigators under the American Recovery and Rein...been awarded grants for investigation of solar phe...f physics, will enhance the capabilities of NJIT,s...
Breaking Biology News(10 mins):Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2PDI and Physicians Interactive Partner To Provide Integrated Personal and Digital Solutions to Life Sciences Companies 14694 1PDI and Physicians Interactive Partner To Provide Integrated Personal and Digital Solutions to Life Sciences Companies 14694 2PDI and Physicians Interactive Partner To Provide Integrated Personal and Digital Solutions to Life Sciences Companies 14694 3Early stage HER2 positive breast cancer patients at increased risk of recurrence 60558 1Early stage HER2 positive breast cancer patients at increased risk of recurrence 60558 2Early stage HER2 positive breast cancer patients at increased risk of recurrence 60558 3ACP expresses support for key policies of Affordable Health Care for America Act 60555 1ACP expresses support for key policies of Affordable Health Care for America Act 60555 2
...g a few extra treats this holiday season? Soon, yo...r exercise routine and keep the pounds off over wi...to keep track. , Researchers at the University of...one applications, dubbed UbiFit and UbiGreen, to a...on. The programs display motivational pictures on ...
...ER 17, 2008 -- One of the biggest threats to today...OC) and soil organic matter (SOM) from poor land-m...ls is essential as they do everything from providi...ul chemical compounds to the prevention of soil er...esidues are critical for maintaining soil producti...
... Department of Energy on Monday awarded $66.9 mill...p at Montana State University to fund a project th...to the sandstone rock layer beneath southwestern W...se of federal funding for the Big Sky partnership,...of the federal money will stay on the MSU campus t...
Other Biology News:Track your fitness, environmental impact with new cell phone applications 2Track your fitness, environmental impact with new cell phone applications 3A model to measure soil health in the era of bioenergy 2Montana State partnership receives $66.9M for carbon sequestration 2Montana State partnership receives $66.9M for carbon sequestration 3
...f-the-art software for all your biopharmaceutical ...duling in a single, scalable software package. The...ent, simplifying the control of all Freedom instru... EVO 100 with one liquid handling arm up to multi-...
iQ Imaging Software from Andor Technology
...it provides all the reagents required for preparin...tion procedure involves tissue homogenization, hyp...ial centrifugation followed by an OptiPrep density...fic for synaptophysin, a synaptic vesicle marker, ...
Hybridization tubes from Sigma-Aldrich
Biology Products: